Secukinumab treatment demonstrated high drug survival and sustained effectiveness in patients with severe chronic plaque psoriasis: 21-month analysis in Australian routine clinical practice (SUSTAIN study).

Peter Foley Nicholas ManuelpillaiCon DolianitisGeoffrey D CainsEric MateRebecca TronnbergChristopher Baker

Published in: The Australasian journal of dermatology (2022)

Secukinumab demonstrated high drug survival and sustained effectiveness in Australian real-world setting, in biologic-naïve and biologic-experienced patients with severe CPP.

Keyphrases

clinical practice
rheumatoid arthritis
ankylosing spondylitis
drug induced
randomized controlled trial
systematic review
early onset
free survival
coronary artery disease
adverse drug
emergency department
systemic lupus erythematosus
electronic health record